Key facts
- It has raised $17.6M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include Gaingels, SaaS Ventures, Tau Ventures, Tech Square Ventures, Endeavor Greece — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Dyania Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Dyania Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dyania Health
Developer of a regulatory-compliant platform designed for empowering clinical research. The company's platform uses artificial intelligence and machine learning to facilitate the accurate identification of potential candidates for clinical drug trials by algorithmically analyzing unstructured electronic medical record data for life-endangering conditions, enabling medical companies to improve the productivity and efficiency of clinical research teams.
- Sector
- Healthcare
- HQ
- Jersey City, NJ, United States
- Founded
- 2019
- Employees
- 44
- Website
- dyaniahealth.com/
- Ownership
- Privately Held (backing)
Dyania Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dyania Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dyania Health in its N-PORT filings yet. We sweep new filings monthly.